Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
rhipe is a leading cloud channel company and software distributor based in Australia, specializing in subscription-based cloud licenses and services across the Asia-Pacific region. Founded in 2003 as NewLease, the company provides licensing, business development, and knowledge services to help IT resellers and service providers transition to cloud-centric business models. Its core offering is the PRISM platform, which automates the provisioning, billing, and management of cloud subscriptions for major vendors such as Microsoft, VMware, and Citrix. In 2021, rhipe was acquired by the Norwegian IT advisory firm Crayon for approximately AUD 408 million, subsequently becoming a key part of Crayon's global expansion strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on rhipe.